This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

CR Bard Inc (BCR)

NYSE: Health Care

Company Income Statement
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Sales 3.05B 2.96B 2.90B 2.72B
Cost of Sales 1.05B 989.00M 982.20M 915.10M
Gross Operating Profit 2.00B 1.97B 1.91B 1.81B
Selling, General, and Administrative Expenses 920.30M 817.30M 1.04B 759.80M
Research & Development 295.70M 203.20M 185.40M 185.40M
Operating Income before D & A (EBITDA) 785.50M 948.60M 687.70M 859.90M
Depreciation & Amortization 146.40M 136.30M 115.10M 104.90M
Interest Income 1.30M 5.50M 3.50M 0.00
Other Income - Net 1.05B -45.80M -3.20M -20.90M
Special Income / Charges -433.20M 0.00 -13.50M 0.00
Total Income Before Interest Expenses (EBIT) 1.26B 772.00M 547.20M 734.10M
Interest Expense 45.00M 39.60M 36.40M 16.40M
Pre-Tax Income 1.21B 732.40M 510.80M 717.70M
Income Taxes 523.60M 202.30M 182.80M 208.10M
Minority Interest 0.00 0.00 0.00 400.00K
Net Income From Continuing Operations 689.80M 530.10M 328.00M 509.60M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations 689.80M 530.10M 328.00M 509.60M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income 689.80M 530.10M 328.00M 509.20M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
1.12B 530.10M 353.70M 509.60M
Preferred Dividends
Net Income Available To Common 689.80M 530.10M 328.00M 509.60M
Basic EPS from Continuing Ops. 8.70 6.36 3.82 5.45
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations 8.70 6.36 3.82 5.45
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) -0.16 -0.12 -0.07 -0.06
Basic EPS, Total 8.54 6.24 3.75 5.39
Basic Normalized Net Income/Share 14.13 6.36 4.12 5.45
EPS fr Continuing Ops. 8.55 6.28 3.76 5.38
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. 8.55 6.28 3.76 5.38
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) -0.16 -0.12 -0.07 -0.06
EPS, Total 8.39 6.16 3.69 5.32
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
13.89 6.28 4.05 5.38
Dividends Paid per Share 0.82 0.78 0.74 0.70
BCR News

Analysts Ratings for BCR

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 1 1 1 1
Moderate Buy 1 1 1 1
Hold 9 9 9 9
Moderate Sell 1 1 1 1
Strong Sell 1 1 1 1
GET BCR ANALYST REPORT

Brokerage Partners

BCR Chatter

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Breakout Stocks

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs